Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Survival Analysis of Patients with Brain Metastsis by Weighting According to the Primary Tumor Oncotype

전이성 뇌종양 환자에서 원발 종양 가중치에 따른 생존율 분석

  • Gwak, Hee-Keun (Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine) ;
  • Kim, Woo-Chul (Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine) ;
  • Kim, Hun-Jung (Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine) ;
  • Park, Jung-Hoon (Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine) ;
  • Song, Chang-Hoon (Department of Radiation Oncology, Inha University Hospital, Inha University School of Medicine)
  • 곽희근 (인하대학교 의과대학 인하대학교병원 방사선종양학교실) ;
  • 김우철 (인하대학교 의과대학 인하대학교병원 방사선종양학교실) ;
  • 김헌정 (인하대학교 의과대학 인하대학교병원 방사선종양학교실) ;
  • 박정훈 (인하대학교 의과대학 인하대학교병원 방사선종양학교실) ;
  • 송창훈 (인하대학교 의과대학 인하대학교병원 방사선종양학교실)
  • Received : 2009.06.03
  • Accepted : 2009.09.03
  • Published : 2009.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study was performed to retrospectively analyze patient survival by weighting according to the primary tumor oncotype in 160 patients with brain metastasis and who underwent whole brain radiotherapy. Materials and Methods: A total of 160 metastatic brain cancer patients who were treated with whole brain radiotherapy of 30 Gy between 2002 and 2008 were retrospectively analyzed. The primary tumor oncotype of 20 patients was breast cancer, and that of 103 patients was lung cancer. Except for 18 patients with leptomeningeal seeding, a total of 142 patients were analyzed according to the prognostic factors and the Recursive Partitioning Analysis (RPA) class. Weighted Partitioning Analysis (WPA), with the weighting being done according to the primary tumor oncotype, was performed and the results were correlated with survival and then compared with the RPA Class. Results: The median survival of the patients in RPA Class I (8 patients) was 20.0 months, that for Class II (76 patients) was 10.0 months and that for Class III (58 patients) was 3.0 months (p<0.003). The median survival of patients in WPA Class I (3 patients) was 36 months, that for the patients in Class II (9 patients) was 23.7 months, that for the patients in Class III (70 patients) was 10.9 months and that for the patients in Class IV (60 patients) was 8.6 months (p<0.001). The WPA Class might have more accuracy in assessing survival, and it may be superior to the RPA Class for assessing survival. Conclusion: A new prognostic index, the WPA Class, has more prognostic value than the RPA Class for the treatment of patients with metastatic brain cancer. This WPA Class may be useful to guide the appropriate treatment of metastatic brain lesions.

목 적: 전이성 뇌종양 환자에서 전뇌조사를 시행받은 160명의 환자를 대상으로 원발 종양 가중치에 따른 생존율을 후향적으로 분석해보고자 하였다. 대상 및 방법: 2002년부터 2008년 사이에 인하대병원에서 전이성 뇌종양으로 진단받은 암환자들 중 전뇌 조사 방사선 치료 30 Gy를 받은 160명의 환자를 대상으로 후향적으로 분석하였다. 원발성 종양이 유방암인 경우는 20명, 폐암인 경우는 103명이었다. 160명의 환자 중 척수 연수막 전이(leptomeningeal seeding) 환자를 제외한, 142명의 환자를 대상으로 예후 인자 및 Recursive Partitioning Aanalysis (RPA) 분류에 따른 생존율, 중앙생존기간과, RPA 분류에 원발 종양의 종류에 따라 가중치를 둔 새로운 Weighted Partitioning Analysis (WPA) 분류에 따른 생존율과 중앙생존기간을 분석하였고 RPA분류와 비교 분석하였다. 결 과: RPA분류에 의한 중앙생존기간은 분류 I (8명), 분류 II (76명), 분류 III (58명)가 각각 20.0개월, 10.0개월, 3.0개월이었으며(p=0.003), WPA 분류의 경우에는 분류 I (3명), 분류 II (9명), 분류 III (70명), 분류 IV (60명)가 각각 36개월, 23.7개월, 10.9개월, 8.6개월로(p=0.001) RPA 분류보다 더 우위성을 보였다. 결 론: 새로운 예후 지표인 WPA 분류가 기존의 RPA 분류보다 전이성 뇌종양 환자에서 치료 방침을 결정함에 있어 도움을 줄 것으로 생각된다.

Keywords

References

  1. Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005;23:6207-6219 https://doi.org/10.1200/JCO.2005.03.145
  2. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-751 https://doi.org/10.1016/S0360-3016(96)00619-0
  3. Weltman E, Salvajoli JV, Brandt RA, et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000;46:1155-1161 https://doi.org/10.1016/S0360-3016(99)00549-0
  4. Sperduto PW, Berkey B, Gaspar L, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008;70:510-514 https://doi.org/10.1016/j.ijrobp.2007.06.074
  5. Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980;6:1-9 https://doi.org/10.1016/0360-3016(80)90195-9
  6. Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS. The palliation of brain metastases in a favorable patient population: a randomized clinical trail by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:891-895 https://doi.org/10.1016/0360-3016(81)90005-5
  7. Sause WT, Scott C, Krisch R, et al. Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28. Int J Radiat Oncol Biol Phys 1993;26:653-657 https://doi.org/10.1016/0360-3016(93)90284-3
  8. Diener-West M, Dobbins TW, Phillips TL, Nelson DF. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG Study 7916. Int J Radiat Oncol Biol Phys 1989;16:669-673 https://doi.org/10.1016/0360-3016(89)90483-5
  9. White KT, Fleming TR, Laws ER Jr. Single metastasis to the brain.: surgical treatment in 122 consecutive patients. Mayo Clin Proc 1981;56:424-428
  10. Galicich JH, Sundaresan N, Arbit E, et al. Surgical treatment of single brain metastasis: factors associated with survival. Cancer 1980;45:381-386 https://doi.org/10.1002/1097-0142(19800115)45:2<381::AID-CNCR2820450232>3.0.CO;2-J
  11. Pieper DR, Hess KR, Sawaya RE. Role of surgery in the treatment of brain metastses in patients with breast cancer. Ann Surg Oncol 1997;4:481-490 https://doi.org/10.1007/BF02303672
  12. Winston KR, Walsh JW, Fischer EG. Results of operative treatment of intracranial metastatic tumors. Cancer 1980;45:2639-2645 https://doi.org/10.1002/1097-0142(19800515)45:10<2639::AID-CNCR2820451025>3.0.CO;2-O
  13. Sundaresan N, Galicich JH. Surgical treatment of brain metastases: clinical and computerized tomography evaluation of the results of treatment. Cancer 1985;55:1382-1388 https://doi.org/10.1002/1097-0142(19850315)55:6<1382::AID-CNCR2820550637>3.0.CO;2-Z
  14. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990;322:494-500 https://doi.org/10.1056/NEJM199002223220802
  15. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al. Treatment of single brain metastasis: radiotherpy alone or combined with neurosurgery? Ann Neurol 1993;33:583-590 https://doi.org/10.1002/ana.410330605
  16. Schoggl A, Kitz K, Reddy M, et al. Defining the role of stereotactic radiosurgery versus microsurgery in the treatment of single brain metastases. Acta Neurochir (Wien) 2000;142:621-626 https://doi.org/10.1007/s007010070104
  17. O'Neill BP, Ituria NJ, Link MJ, Pollock BE, Ballman KV, O'Fallon JR. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys 2003;55:1169-1176 https://doi.org/10.1016/S0360-3016(02)04379-1
  18. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295:2483-2491 https://doi.org/10.1001/jama.295.21.2483
  19. Sneed PK, Suh JH, Goetsch SJ, et al. A multiinstitutional review of radiosurgery alone vs radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002;53:519-526 https://doi.org/10.1016/S0360-3016(02)02770-0
  20. Sneed PK, Lamborn KR, Forstner JM, et al. Radiosurgery or brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999;43:549-558 https://doi.org/10.1016/S0360-3016(98)00447-7
  21. Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998;16:3563-3569 https://doi.org/10.1200/JCO.1998.16.11.3563
  22. Flickinger JC, Kondziolka D, Lunsford LD, et al. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 1994;28:797-802 https://doi.org/10.1016/0360-3016(94)90098-1
  23. Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007;68:1388-1395 https://doi.org/10.1016/j.ijrobp.2007.03.048
  24. Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 2002;52:333-338 https://doi.org/10.1016/S0360-3016(01)02645-1
  25. Regine WF, Scott C, Murray K, et al. Neurocognitive outcome in brain metastasis patients treated with accelerated fractionation vs accelerated hyperfractionation whole brain radiotherapy: an analysis from RTOG Study 91-04. Int J Radiat Oncol Biol Phys 2001;51:711-717 https://doi.org/10.1016/S0360-3016(01)01676-5
  26. DeAngelis LM, Delattre JY, Posner JB. Radiationinduced dementia in patients cured of brain metastases. Neurology 1989;39:789-796 https://doi.org/10.1212/WNL.39.6.789
  27. Asai A, Matsutani M, Kohno T, et al. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 1989;63:1962-1974 https://doi.org/10.1002/1097-0142(19890515)63:10<1962::AID-CNCR2820631016>3.0.CO;2-V

Cited by

  1. Survival Outcomes after Whole Brain Radiation Therapy and/or Stereotactic Radiosurgery for Cancer Patients with Metastatic Brain Tumors in Korea: A Systematic Review vol.14, pp.12, 2013, https://doi.org/10.7314/apjcp.2013.14.12.7401